Novel roles of phosphoinositides in signaling, lipid transport, and disease

GRV Hammond, JE Burke - Current Opinion in Cell Biology, 2020 - Elsevier
Phosphoinositides (PPIns) are lipid signaling molecules that act as master regulators of
cellular signaling. Recent studies have revealed novel roles of PPIns in myriad cellular …

The Src module: an ancient scaffold in the evolution of cytoplasmic tyrosine kinases

NH Shah, JF Amacher, LM Nocka… - Critical reviews in …, 2018 - Taylor & Francis
Tyrosine kinases were first discovered as the protein products of viral oncogenes. We now
know that this large family of metazoan enzymes includes nearly one hundred structurally …

Bruton's Tyrosine Kinase Inhibitors with Distinct Binding Modes Reveal Differential Functional Impact on B-Cell Receptor Signaling

W Li, R Sano, M Apatira, F DeAnda, T Gururaja… - Molecular Cancer …, 2024 - AACR
Small molecule inhibitors of Bruton's tyrosine kinase (BTK) have been approved for the
treatment of multiple B-cell malignancies and are being evaluated for autoimmune and …

A combined approach reveals a regulatory mechanism coupling Src's kinase activity, localization, and phosphotransferase-independent functions

E Ahler, AC Register, S Chakraborty, L Fang, EM Dieter… - Molecular cell, 2019 - cell.com
Multiple layers of regulation modulate the activity and localization of protein kinases.
However, many details of kinase regulation remain incompletely understood. Here, we apply …

Structural mechanism for Bruton's tyrosine kinase activation at the cell membrane

Q Wang, Y Pechersky, S Sagawa… - Proceedings of the …, 2019 - National Acad Sciences
Bruton's tyrosine kinase (Btk) is critical for B cell proliferation and activation, and the
development of Btk inhibitors is a vigorously pursued strategy for the treatment of various B …

Differential impact of BTK active site inhibitors on the conformational state of full-length BTK

RE Joseph, N Amatya, DB Fulton, JR Engen, TE Wales… - Elife, 2020 - elifesciences.org
Bruton's tyrosine kinase (BTK) is targeted in the treatment of B-cell disorders including
leukemias and lymphomas. Currently approved BTK inhibitors, including Ibrutinib, a first-in …

Polyphosphoinositide-binding domains: Insights from peripheral membrane and lipid-transfer proteins

JG Pemberton, T Balla - Protein Reviews–Purinergic Receptors: Volume …, 2019 - Springer
Within eukaryotic cells, biochemical reactions need to be organized on the surface of
membrane compartments that use distinct lipid constituents to dynamically modulate the …

The HIV-1 protein Nef activates the Tec family kinase Btk by stabilizing an intermolecular SH3-SH2 domain interaction

M Aryal, D Lin, K Regan, S Du, H Shi, JJ Alvarado… - Science …, 2022 - science.org
The Nef protein produced by the viruses HIV-1 and SIV drives efficient viral replication
partially by inducing constitutive activation of host cell tyrosine kinases, including members …

BTK inhibitors synergise with 5‐FU to treat drug‐resistant TP53‐null colon cancers

M Lavitrano, L Ianzano, S Bonomo… - The Journal of …, 2020 - Wiley Online Library
Colorectal cancer (CRC) is the fourth cause of death from cancer worldwide mainly due to
the high incidence of drug‐resistance. During a screen for new actionable targets in drug …

Bruton's tyrosine kinase, a component of B cell signaling pathways, has multiple roles in the pathogenesis of lupus

AB Satterthwaite - Frontiers in immunology, 2018 - frontiersin.org
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the loss of
adaptive immune tolerance to nucleic acid-containing antigens. The resulting …